Vermillion Emerges from Bankruptcy Protection | GenomeWeb

NEW YORK (GenomeWeb News) - Vermillion today said that it has emerged from US Bankruptcy Protection less than 10 months after filing for Chapter 11.

The Fremont, Calif.-based molecular diagnostics firm said that all of its creditors have received 100 percent of allowed claims. It also said that its common stock has been fully restated.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: phosphoproteomic patterns in prostate cancer, effect of gene expression on fitness in yeast, and more.

Scripps Research Institute investigators peer back at the RNA world.

Being born premature shouldn't mean infants with high blood sugar levels don't undergo genetic testing for neonatal diabetes, a study in Pediatrics says.

In PNAS this week: chromosome instability in S. cerevisiae, structural differences and sequence divergence in rice, and more.